Scan to Download
One power score. Smarter investment decisions
Fibrobiologics Inc
FBLG0.532USD
-0.003-0.49%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
21.76MMarket Cap
LossP/E TTM
Fibrobiologics Inc
0.532
-0.003-0.49%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Operating expenses
39.27%4.49M
31.33%4.53M
49.68%3.71M
63.43%3.35M
54.04%3.22M
52.32%3.45M
90.18%2.48M
52.95%2.05M
--2.09M
--2.27M
--1.30M
--1.34M
R&D expenses
109.33%2.04M
85.42%1.78M
75.42%1.36M
111.32%1.21M
79.56%975.00K
100.84%960.00K
124.06%773.00K
64.94%574.00K
--543.00K
--478.00K
--345.00K
--348.00K
Depreciation, depletion, and amortization
456.76%206.00K
360.00%161.00K
51.61%47.00K
192.31%38.00K
1750.00%37.00K
3400.00%35.00K
--31.00K
--13.00K
--2.00K
--1.00K
----
--0.00
Operating profit
-39.27%-4.49M
-31.33%-4.53M
-49.68%-3.71M
-63.43%-3.35M
-54.04%-3.22M
-52.32%-3.45M
-90.18%-2.48M
-52.95%-2.05M
---2.09M
---2.27M
---1.30M
---1.34M
Net non-operating interest income (expenses)
Non-operating interest income
-28.57%50.00K
153.85%99.00K
--63.00K
--79.00K
--70.00K
--39.00K
----
----
----
--0.00
----
----
Non-operating interest expense
-100.00%0.00
-100.00%0.00
500.00%6.00K
--5.00K
-54.55%5.00K
-97.04%4.00K
-99.55%1.00K
-100.00%0.00
--11.00K
--135.00K
--220.00K
--221.00K
Special income (expenses)
-89.89%407.00K
82.80%-534.00K
131.16%2.25M
--2.78M
--4.03M
---3.10M
---7.24M
----
----
--0.00
----
----
Other non-operating income (expenses)
-2183.33%-625.00K
100.00%0.00
---1.70M
101.42%2.00K
152.63%30.00K
-12840.00%-1.94M
----
---141.00K
---57.00K
---15.00K
----
--0.00
Income before tax
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-250.31%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
---1.52M
---1.56M
Income after tax
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-250.31%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
---1.52M
---1.56M
Net income from continuous operations
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-250.31%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
---1.52M
---1.56M
Net income attributable to controlling interests
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-69.61%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---4.99M
---1.52M
---1.56M
Net income attributable to common shareholders
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-69.61%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---4.99M
---1.52M
---1.56M
Basic earnings per share
-539.20%-0.12
50.17%-0.14
85.52%-0.09
77.89%-0.01
141.25%0.03
-76.93%-0.27
-1236.54%-0.63
-40.31%-0.07
---0.07
---0.15
---0.05
---0.05
Diluted earnings per share
-539.20%-0.12
50.17%-0.14
85.52%-0.09
77.89%-0.01
141.25%0.03
-76.93%-0.27
-1236.54%-0.63
-40.31%-0.07
---0.07
---0.15
---0.05
---0.05
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
